Advertisement

Advertisement

Expert���s Corner

Advertisement

Advertisement



Dec
18
Today In Oncology
ASCO and ESMO Publish Joint Assessment of Their Value Frameworks
Pembrolizumab vs Standard of Care in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Addition of Neoadjuvant Palbociclib to Letrozole in Estrogen Receptor–Positive Early Breast Cancer
FDA Approves Romiplostim for Pediatric Patients With Immune Thrombocytopenia
FDA Approves Trastuzumab-pkrb for HER2-Overexpressing Breast Cancer
View More 
;
Advertisement
Most Read Stories
Ibrutinib vs Standard of Care in Front-Line Treatment of Older Patients With Chronic Lymphocytic Leukemia
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
Local Consolidative Therapy Associated With Survival Benefit for Some With Oligometastatic NSCLC
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
Apixaban Thromboprophylaxis in Patients With Cancer
View More 
Most Viewed Videos
Harold J. Burstein, MD, PhD, and Daniel F. Hayes, MD, on Breast Cancer With Positive Lymph Nodes: Treatment Controversy
Hope S. Rugo, MD, on Immunotherapy for Breast Cancer: Expert Perspective
Judy E. Garber, MD, on Cancer Genetics: Updates for Breast Cancer Care
Paul Richardson, MD, on Multiple Myeloma: Results From the OP-106 Horizon Trial
Xavier Pivot, MD, PhD, on Early Breast Cancer: Results From the PHARE Trial
View More 
© 2018 HSP News Service, L.L.C.